- Home
- ODV vs RCKT Comparison
ODV vs RCKT Comparison
Compare ODV & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODV
- RCKT
- Stock Information
- Founded
- ODV 2005
- RCKT 1999
- Country
- ODV Canada
- RCKT United States
- Employees
- ODV N/A
- RCKT N/A
- Industry
- ODV Precious Metals
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ODV Basic Materials
- RCKT Health Care
- Exchange
- ODV Nasdaq
- RCKT Nasdaq
- Market Cap
- ODV 338.9M
- RCKT 328.6M
- IPO Year
- ODV N/A
- RCKT N/A
- Fundamental
- Price
- ODV $2.54
- RCKT $3.05
- Analyst Decision
- ODV
- RCKT Buy
- Analyst Count
- ODV 0
- RCKT 13
- Target Price
- ODV N/A
- RCKT $12.88
- AVG Volume (30 Days)
- ODV 877.5K
- RCKT 2.6M
- Earning Date
- ODV 08-12-2025
- RCKT 08-07-2025
- Dividend Yield
- ODV N/A
- RCKT N/A
- EPS Growth
- ODV N/A
- RCKT N/A
- EPS
- ODV N/A
- RCKT N/A
- Revenue
- ODV $5,147,156.00
- RCKT N/A
- Revenue This Year
- ODV $344.23
- RCKT N/A
- Revenue Next Year
- ODV $70.34
- RCKT $591.46
- P/E Ratio
- ODV N/A
- RCKT N/A
- Revenue Growth
- ODV N/A
- RCKT N/A
- 52 Week Low
- ODV $1.16
- RCKT $2.19
- 52 Week High
- ODV $2.75
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- ODV 58.94
- RCKT 49.19
- Support Level
- ODV $2.43
- RCKT $2.83
- Resistance Level
- ODV $2.65
- RCKT $3.22
- Average True Range (ATR)
- ODV 0.13
- RCKT 0.17
- MACD
- ODV 0.01
- RCKT 0.01
- Stochastic Oscillator
- ODV 77.60
- RCKT 41.51
About ODV Osisko Development Corp.
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.